[Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
D020909:Acarbose; D001786:Blood Glucose / Q000378:metabolism; D050260:Carbohydrate Metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D005951:Glucose Tolerance Test; D005959:Glucosidases / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D008297:Male; D008875:Middle Aged; D009844:Oligosaccharides / Q000494:pharmacology*; D014312:Trisaccharides / Q000494:pharmacology*
D001786:Blood Glucose; D065089:Glycoside Hydrolase Inhibitors; D009844:Oligosaccharides; D014312:Trisaccharides; D005959:Glucosidases; D020909:Acarbose
Beeinflussung des Kohlenhydratstoffwechsels und der OGTT bei Typ-II-Diabetikern durch den Glukosidaseinhibitor Acarbose.